Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
4.600
-0.060 (-1.29%)
At close: Jun 27, 2025, 4:00 PM
4.590
-0.010 (-0.22%)
After-hours: Jun 27, 2025, 7:41 PM EDT

Monte Rosa Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
283426283368950-
Upgrade
Market Cap Growth
-19.26%50.74%-23.21%-61.22%--
Upgrade
Enterprise Value
-1228151142583-
Upgrade
Last Close Price
4.606.945.657.6120.42-
Upgrade
PS Ratio
2.295.64----
Upgrade
PB Ratio
1.031.911.581.362.73-
Upgrade
P/TBV Ratio
1.031.911.581.362.73-
Upgrade
P/FCF Ratio
9.2811.22----
Upgrade
P/OCF Ratio
8.1610.15----
Upgrade
EV/Sales Ratio
-3.01----
Upgrade
EV/FCF Ratio
-6.00----
Upgrade
Debt / Equity Ratio
0.150.190.260.17--
Upgrade
Debt / FCF Ratio
1.371.12----
Upgrade
Asset Turnover
0.480.20----
Upgrade
Quick Ratio
5.532.375.0010.5820.801.43
Upgrade
Current Ratio
5.612.405.0710.7920.961.49
Upgrade
Return on Equity (ROE)
2.88%-36.15%-60.07%-35.06%-40.35%-277.72%
Upgrade
Return on Assets (ROA)
-0.40%-13.66%-27.72%-19.82%-21.92%-57.90%
Upgrade
Return on Capital (ROIC)
-0.52%-20.65%-32.95%-21.09%-24.85%-131.69%
Upgrade
Earnings Yield
2.17%-17.05%-47.85%-29.46%-7.79%-
Upgrade
FCF Yield
10.77%8.91%-22.22%-28.61%-7.28%-
Upgrade
Buyback Yield / Dilution
-47.16%-43.80%-8.83%-88.91%-1548.09%-7.11%
Upgrade
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q